Top Markets
Coin of the day
Monterey Bio Acquisition Corporation Monterey Bio Acquisition Corporation

Monterey Bio Acquisition Corporation

MTRY
Rang in Aktien #19499
Monterey Bio Acquisition Corporation currently lacks substantial operational... Monterey Bio Acquisition Corporation currently lacks substantial operational activities. Its primary goal is to achieve a business combination—including but not limited to mergers, capital stock exchanges, asset acquisitions, or reorganizations—with companies in the biotechnology industry. The firm, established in 2020, was formerly known as Chardan FinTech Acquisition Corp. and rebranded to Monterey Bio Acquisition Corporation in April 2021. It is headquartered in New York, New York.
Aktienkurs
$11.14
Zuletzt synchronisiert: 2023-11-28
Marktkapitalisierung
$160.14M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Monterey Bio Acquisition Corporation (MTRY)
Dividendenrendite-Verlauf für Monterey Bio Acquisition Corporation (MTRY)
Dividendenrendite (TTM) von Monterey Bio Acquisition Corporation (Aktienkürzel: MTRY) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Monterey Bio Acquisition Corporation (MTRY) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber